Entinostat is a synthetic benzamide derivative class I histone deacetylase (HDAC) inhibitor that can inhibit cell proliferation and promote breast cancer cell apoptosis, thereby treating breast cancer (Trapani et al., 2017). This evidence concerns the gene HDAC9 and breast carcinoma.